Shareholding disclosure

Credit Suisse Group AG

Declared position

Threshold

Fell below threshold

Timeline

Published

15.02.2019

Transaction

07.02.2019

Voting rights breakdown

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAJ2D00029

Beneficial owner

Credit Suisse Group AG

Declared address

Credit Suisse Group AG, Zürich

Rückübertragung Effektenleihe

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Credit Suisse Group AG

Basilea Pharmaceutica AG, Allschwil15.02.2019TAJ2D00029

Disclosure summary

Credit Suisse Group AG disclosed a holding in Basilea Pharmaceutica AG, Allschwil that fell below the publication threshold, published by SIX Exchange Regulation on 15.02.2019, at 3% of voting rights. Notice category: Single shareholder.

Disclosed position

Below threshold

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Credit Suisse Group AG disclosed a holding in Basilea Pharmaceutica AG, Allschwil, published on 15.02.2019.

Publication date15.02.2019

Transaction date07.02.2019

Issuing companyBasilea Pharmaceutica AG, Allschwil

Beneficial ownerCredit Suisse Group AG

Declared addressCredit Suisse Group AG, Zürich

CategorySingle shareholder

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

ExchangeXSWX

Notification IDTAJ2D00029

Commercial register

CHE-105.884.494

Struck off the register · 14.06.2023

Zefix record

Conditions

Rückübertragung Effektenleihe

Source: SIX Exchange Regulation · Publication date: 15.02.2019

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open